Laatste update :
19/11/2024
geneesmiddel tegen kanker   Mercaptopurine  
Orale Oplossing
Stabiliteit van farmaceutische preparaten Stabiliteit in mengsels Factoren die de stabiliteit beïnvloeden Verenigbaarheden Literatuur pdf
   Molecuulstructuur  

Orale Oplossing
Literatuur   Orale Oplossing   Literatuur : Mercaptopurine  
type publicatie
2396 Artikel Aliabadi HM, Romanick M, Desai S, Lavasanifar A.
Effect of buffer and antioxidant on stability of a mercaptopurine suspension
Am J Health-Syst Pharm 2008 ; 65: 441-447.
3244 Poster Sutra C, Guillemot C, Monnier S, Puiset F, Canonge JM.
Stabilité chimique et microbiologique d'une suspension de mercaptopurine à 5 mg/mL.
SFPO Congress Mandelieu, France 2011
3843 Artikel Peacock G.F, Sauvageot J, Hill A, Killian A.
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
Int J Pharm Compound 2016 ; 20, 1: 81-85
4177 Artikel Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526

  Mentions Légales